AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Glucotrack reported Q2 GAAP EPS of -$9.62, with cash and cash equivalents at $9.6 million as of June 30, 2025, compared to $5.6 million as of December 31, 2024.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet